By Joel Kahn, MD, FACC
Topics: Joel Kahn, MD, FACC
Topics: Joel Kahn, MD, FACC, Kristine Burke, MD
Topics: Joel Kahn, MD, FACC
Numerous cellular, animal and human studies have been conducted to evaluate the biological activities, mode of mechanisms, and therapeutic benefits of Arterosil, a patent-pending nutraceutical. Studies include:
Download Arterosil's Research Summary here.
*These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure or prevent any disease.
U.S. Patent No. 11,135,238. International Patents Pending.
© 2022 Calroy Health Sciences. All rights reserved.